3-amino-2-methylbenzamide, 95.0%, 5g

N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide, 97.0%, 25g

HPLC column NUCLEODUR® NH2 5 µm, 125 mm, 4.6 mm, 1 Piece(s)

5-Chloro-2-hydroxy-4-methylbenzophenone>98.0%(GC)25g

Methyl 1-benzyl-4-oxo-3-piperidinecarboxylate hydrochloride, 95.0%, 100g

2,4,6-Tris(2,4,6-tribromophenoxy)-1,3,5-triazine, 98%, 500g

2-(PIPERIDIN-4-YL)PROPAN-2-AMINE 2HCL, 95.0%, 100mg

4,4''-Dimethoxy-1,1':4',1''-terphenyl, 95%, 1g

Thiopropionamide, 98.0%, 10g

2-Bromo-7-iodo-9H-fluorene, 95.0%, 1g

Crizotinib, 95%, 500mg

Methyl hydrazinocarboxylate, 98.00%, 1g

(4-Chlorophenyl)(phenyl)methanone, 99.00%, 500g